Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeBiotech

      Biotech

      CIMG Inc. Announces Entry into Computing Power Industry; Initial Contracts with Aggregate Value of Approximately $124 Million
      Biotech

      CIMG Inc. Announces Entry into Computing Power Industry; Initial Contracts with Aggregate Value of Approximately $124 Million

      January 6, 2026
      GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy
      Biotech

      GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy

      January 5, 2026
      Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference
      Biotech

      Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference

      January 4, 2026
      MarathonLS and Pacer Announce Strategic Separation into Two Independent Organizations
      Biotech

      MarathonLS and Pacer Announce Strategic Separation into Two Independent Organizations

      January 3, 2026
      Last day of trading in shares with pre-emptive rights in connection with rights issue
      Biotech

      Last day of trading in shares with pre-emptive rights in connection with rights issue

      January 2, 2026
      The End of Shots? 5 Biotech Stocks Rethinking Diabetes
      Biotech

      The End of Shots? 5 Biotech Stocks Rethinking Diabetes

      January 1, 2026
      Mabwell Announces First Patient Dosed in Phase II Trial of Anti-IL-11 Antibody for Pathological Scarring
      Biotech

      Mabwell Announces First Patient Dosed in Phase II Trial of Anti-IL-11 Antibody for Pathological Scarring

      December 31, 2025
      Equanimity AI to Debut Beacon, an AI-Operated Pain OS, at NANS 2026
      Biotech

      Equanimity AI to Debut Beacon, an AI-Operated Pain OS, at NANS 2026

      December 30, 2025
      CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596
      Biotech

      CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Product CT0596

      December 29, 2025
      Mabwell Receives IND Clearance for Novel Anti-ST2 Monoclonal Antibody 9MW1911 to Initiate Phase IIa Study
      Biotech

      Mabwell Receives IND Clearance for Novel Anti-ST2 Monoclonal Antibody 9MW1911 to Initiate Phase IIa Study

      December 28, 2025
      1 2 3 … 177 »

       

      LATEST NEWS

      • Investing News RPM’s Economic and Weather Challenges
      • Investing News Investment Insights on Top Stocks
      • Investing News Stellantis Reports 68-Year Low in Production
      • Investing News Top Quantum Computing Stocks to Watch
      • Investing News Rivian Achieves 2024 Production Goal

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026